| Product NDC: | 0173-0739 |
| Proprietary Name: | IMITREX |
| Non Proprietary Name: | sumatriptan succinate |
| Active Ingredient(s): | 4 mg/.5mL & nbsp; sumatriptan succinate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0739 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020080 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060406 |
| Package NDC: | 0173-0739-00 |
| Package Description: | 2 SYRINGE in 1 PACKAGE (0173-0739-00) > .5 mL in 1 SYRINGE |
| NDC Code | 0173-0739-00 |
| Proprietary Name | IMITREX |
| Package Description | 2 SYRINGE in 1 PACKAGE (0173-0739-00) > .5 mL in 1 SYRINGE |
| Product NDC | 0173-0739 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sumatriptan succinate |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20060406 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | SUMATRIPTAN SUCCINATE |
| Strength Number | 4 |
| Strength Unit | mg/.5mL |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |